Sign in
8-K

Current Report

Damora Therapeutics, Inc. Filed Acc 0001193125-26-099404

Results of operations · Bylaws or fiscal year change · Regulation FD disclosure

  • Item 2.02 Results of operations and financial condition
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading dmra-20260306.htm…